What Are the Challenges in Developing Cancer Nano Medicines?
Despite their potential, several challenges remain in the development of nano medicines for cancer:
- Biocompatibility and Toxicity: Ensuring that nanoparticles are safe and do not elicit unwanted immune responses is crucial. - Manufacturing and Scaling Up: Producing nanoparticles consistently and at a large scale can be technically challenging and costly. - Regulatory Hurdles: Navigating the regulatory landscape for approval of nano medicines is complex and requires comprehensive evaluation of safety and efficacy.
